These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


504 related items for PubMed ID: 21989075

  • 1. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
    Hirasawa Y, Sakai T, Ito M, Yoshimura H, Feng Y, Nagamatsu T.
    Eur J Pharmacol; 2011 Dec 15; 672(1-3):159-68. PubMed ID: 21989075
    [Abstract] [Full Text] [Related]

  • 2. Extract of Cassiae Semen and its major compound inhibit S100b-induced TGF-beta1 and fibronectin expression in mouse glomerular mesangial cells.
    Jung DH, Kim YS, Kim NH, Lee J, Jang DS, Kim JS.
    Eur J Pharmacol; 2010 Sep 01; 641(1):7-14. PubMed ID: 20483351
    [Abstract] [Full Text] [Related]

  • 3. KIOM-79 prevents S100b-induced TGF-beta1 and fibronectin expression in mouse mesangial cells.
    Jung DH, Kim YS, Kim JS.
    J Ethnopharmacol; 2009 Sep 25; 125(3):374-9. PubMed ID: 19666101
    [Abstract] [Full Text] [Related]

  • 4. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.
    Kim YS, Kim BC, Song CY, Hong HK, Moon KC, Lee HS.
    J Lab Clin Med; 2001 Jul 25; 138(1):59-68. PubMed ID: 11433229
    [Abstract] [Full Text] [Related]

  • 5. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
    Song CY, Kim BC, Lee HS.
    Transl Res; 2008 Jan 25; 151(1):27-35. PubMed ID: 18061125
    [Abstract] [Full Text] [Related]

  • 6. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS, Kim NH, Lee SW, Lee YM, Jang DS, Kim JS.
    Eur J Pharmacol; 2007 Aug 27; 569(3):171-9. PubMed ID: 17597607
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G, Pricci F, Romeo G, Pugliese F, Mené P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U.
    Diabetes; 1997 Nov 27; 46(11):1881-7. PubMed ID: 9356040
    [Abstract] [Full Text] [Related]

  • 11. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS, Jung DH, Lee IS, Pyun BJ, Kim JS.
    Phytomedicine; 2016 Apr 15; 23(4):388-97. PubMed ID: 27002409
    [Abstract] [Full Text] [Related]

  • 12. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH, Feng L, Zhu MM, Gu JF, Jiang J, Cheng XD, Ding SM, Wu C, Jia XB.
    J Ethnopharmacol; 2014 Apr 15; 151(1):591-600. PubMed ID: 24269777
    [Abstract] [Full Text] [Related]

  • 13. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI, Stanca L, Geicu OI, Munteanu MC, Costache M, Dinischiotu A.
    J Diabetes; 2015 Jan 15; 7(1):114-24. PubMed ID: 24666836
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of three mitogen-activated protein kinases on lipoprotein (a)-induced human mesangial cell proliferation.
    Song HM, Wei M, Xu K, Li XW.
    Chin Med J (Engl); 2010 Jan 20; 123(2):216-20. PubMed ID: 20137374
    [Abstract] [Full Text] [Related]

  • 15. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H, Chihara Y, Kondo H.
    Int J Cancer; 2003 May 10; 104(6):722-7. PubMed ID: 12640679
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ, Kang MK, Kim DY, Kim YH, Oh H, Kang YH.
    Nutrients; 2018 Jul 09; 10(7):. PubMed ID: 29987200
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.